D

Definitive Healthcare Corp
NASDAQ:DH

Watchlist Manager
Definitive Healthcare Corp
NASDAQ:DH
Watchlist
Price: 4.145 USD -0.36%
Market Cap: 642.4m USD
Have any thoughts about
Definitive Healthcare Corp?
Write Note

Definitive Healthcare Corp
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Definitive Healthcare Corp
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
D
Definitive Healthcare Corp
NASDAQ:DH
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
Long-Term Investments
$113.4m
CAGR 3-Years
125%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Long-Term Investments
$50.6m
CAGR 3-Years
38%
CAGR 5-Years
19%
CAGR 10-Years
17%
W
Waystar Holding Corp
NASDAQ:WAY
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Definitive Healthcare Corp
Glance View

Market Cap
641.8m USD
Industry
Health Care

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 676 full-time employees. The company went IPO on 2021-09-15. The firm provides solutions through its software-as-a-service (SaaS) platform, which provides information on healthcare providers and their activities to help its customers optimize from product development to go-to-market planning and sales and marketing execution. Its platform offers Artificial Intelligence (AI) engine and Front-end SaaS platform. The firm's platform is embedded with deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The firm provides services across biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers and other diversified companies.

DH Intrinsic Value
4.466 USD
Undervaluation 7%
Intrinsic Value
Price
D

See Also

Back to Top